Browsing Category
Pharmaceuticals
Dr. Reddy’s Laboratories Announces Launch of Oral Semaglutide Biosimilar ‘Obeda®’…
Hyderabad – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”), a global…
HAB Pharma Strengthens Position with Strategic Merger and Expansion Plans for Future…
Bangalore : HAB Pharma and Signature Phytochemicals have completed a strategic merger through a slump sale, bringing both companies under a single consolidated entity. Finalized in March…
Annora Pharma Expands Collaboration with AI-Native Traceability Platform AltiusHub to…
Annora Pharma, the formulations subsidiary of Hetero Group and a leading Indian pharmaceutical manufacturer, has expanded its collaboration with AltiusHub. The company is deploying…
Senores Pharma Closes FY26 on Strong Note, Driven by Portfolio Expansion and Global…
Ahmedabad, Gujarat – Senores Pharmaceuticals Limited reported strong financial and operational performance for the fourth quarter and full year ended March 31, 2026, reflecting sustained…
Lilly Supports Haryana State-FDA Action Against Counterfeit Medicines Reiterates…
Bangalore : Eli Lilly and Company (India) commends the actions taken by the Haryana drug control authority in addressing counterfeit products falsely bearing the Mounjaro® (tirzepatide)…
Sun Pharma signs Definitive Agreement to Acquire Organon
Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and…
ZEE News Exposes Pharma Profiteering, Counterfeit Drug Network Triggers Swift…
New Delhi : Marking World Health Day, ZEE News, known for its impactful public-interest journalism has brought national attention to a critical healthcare challenge through its flagship…
Orbicular Pharmaceutical Technologies Receives U.S. FDA Tentative Approval for…
Hyderabad: Orbicular Pharmaceutical Technologies Pvt. Ltd., a Hyderabad-based leading developer of complex peptide-based generics, announced today that a generic version of Ozempic®…
Emcure Pharmaceuticals Reduces Poviztra Starting Dose Price by 55% to Expand Patient…
Bangalore : Emcure Pharmaceuticals Ltd., (BSE: 544210, NSE: EMCURE) has announced the price revision of its weight management drug Poviztra® (semaglutide injection) across India. The…
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Lamotrigine Orally…
Bengaluru - February 26th, 2026: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its…